Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Psychology, Gothenburg University, Gothenburg, Sweden.
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Eur J Surg Oncol. 2022 Feb;48(2):312-319. doi: 10.1016/j.ejso.2021.09.013. Epub 2021 Sep 20.
Since there are no formal definition of health-related quality of life (HRQOL) there may be a lack of coherence and understanding of how to interpret HRQOL-data. The aim of this study is to summarize HRQOL-results that have used the FACT-M questionnaire in patients with melanoma, and specifically to summarize FACT-M between tumor stage.
This review was conducted in accordance with the PRISMA guidelines.
original studies on cutaneous melanoma between 2005 and 2020, written in English, containing "Functional Assessment of Cancer Therapy Melanoma" OR "Functional Assessment of Cancer Therapy M" OR FACT-M OR FACT/M OR FACTM OR "FACT M" OR FACT-melanoma OR "FACT Melanoma" together with FACT-M numbered data and basic patient characteristics, using the databases Scopus, Web of Science, PubMed and PsycINFO.
16 articles describing 14 patient cohorts published 2008-2020 were included. The majority of the studies did not report subscale scores in accordance with FACT-M guidelines. The results did indicate that FACT-M total scores were inversely correlated with AJCC stage. Subscale analysis demonstrated varying degrees of correlation with AJCC stage. The Melanoma Surgery Subscale score was lowest in stage III patients, probably reflecting more advanced surgical procedures in this group of patients.
Though this review is based on a questionnaire limited to the assessment of melanoma patients, it highlights the universal need for clinical studies to describe their selected HRQOL-questionnaires, its definition of HRQOL and its dimensions, as well as comply with the questionnaire's guidelines when reporting HRQOL-data.
由于目前尚没有健康相关生活质量(HRQOL)的正式定义,因此可能缺乏对如何解释 HRQOL 数据的一致性和理解。本研究的目的是总结在黑色素瘤患者中使用 FACT-M 问卷的 HRQOL 结果,特别是总结肿瘤分期之间的 FACT-M。
本综述是按照 PRISMA 指南进行的。
2005 年至 2020 年间发表的英文原始研究,包含“癌症治疗功能评估-黑色素瘤”或“癌症治疗功能评估 M”或 FACT-M 或 FACT/M 或 FACTM 或“FACT M”或 FACT-黑色素瘤或“FACT 黑色素瘤”,以及 FACT-M 编号数据和基本患者特征,使用 Scopus、Web of Science、PubMed 和 PsycINFO 数据库。
纳入了 16 篇描述 2008 年至 2020 年发表的 14 个患者队列的文章。大多数研究未按照 FACT-M 指南报告亚量表评分。结果表明,FACT-M 总分与 AJCC 分期呈负相关。亚量表分析表明与 AJCC 分期存在不同程度的相关性。III 期患者的黑色素瘤手术亚量表评分最低,可能反映了该组患者更先进的手术程序。
尽管本综述基于仅评估黑色素瘤患者的问卷,但它强调了临床研究普遍需要描述其选择的 HRQOL 问卷、其对 HRQOL 的定义及其维度,以及在报告 HRQOL 数据时遵守问卷指南的必要性。